Photo from archive.org
In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine… Click to show full abstract
In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine.
Keywords:
autoimmune diabetes;
sars cov2;
glucose control;
glucose monitoring;
continuous glucose
Journal Title: Diabetes Research and Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes Research and Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!